Chapter 11

  1. Abkowitz JL. 1991. Retrovirus-induced feline pure red blood cell aplasia: pathogenesis and response to suramin. Blood 77:1442-1451.
  2. Abujamra AL, Spanjaard RA, Akinsheye I, et al. 2006. Leukemia virus long terminal repeat activates NFκB pathway by a TLR3-dependent mechanism. Virology 345:390.
  3. Addie DD, Dennis JM, Toth S, et al. 2000. Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Vet Rec 146:419-424.
  4. Ahmad S, Levy LS. 2010. The frequency of occurrence and nature of recombinant feline leukemia viruses in the induction of multicentric lymphoma by infection of the domestic cat with FeLV-945. Virology 403:103-110.
  5. AIDS Vaccine Evaluation Group 022 Protocol Team. 2001. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 env, gag, and pro in combination with RGP120. J Infect Dis 183:563-570.
  6. American Association of Feline Practitioners. 2006. Feline vaccination guidelines. http://www.catvets.com/professionals/guidelines/publications/?Id=176. Accessed 11/24/10.
  7. American Association of Feline Practitioners/Academy of Feline Medicine (AAFP/AFM) Advisory Panel on Feline Retrovirus Testing and Management. 2001. Feline retrovirus testing and management. Compend Contin Educ Pract Vet 23:652-657, 692.
  8. Andersen BC, Theilen GH. 1980. Continuing studies of feline sarcoma virus induced tumors in newborn lambs and in kittens: a model to study comparative neoplasia. Eur J Cancer 16:925-935.
  9. Anderson LJ, Jarrett WFH. 1971. Membranous glomerulonephritis associated with leukemia in cats. Res Vet Sci 12:179-180.
  10. Anderson MM, Lauring AS, Burns CC, et al. 2000. Identification of a cellular cofactor required for infection by feline leukemia virus. Science 287:1828-1830.
  11. Anonymous. 1999. Vaccine-Associated Feline Sarcoma Task Force guidelines. Diagnosis and treatment of suspected sarcomas. J Am Vet Med Assoc 214:1745.
  12. Anonymous. 2001. Feline practitioners recommend new FIV and FeLV testing guidelines, initiate public awareness campaign. J Am Vet Med Assoc 218:1247.
  13. Arai M, Darman J, Lewis A, et al. 2000. The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats. Vet Immunol Immunopathol 77:71-92.
  14. Arjona A, Barquero N, Doménech A, et al. 2007. Evaluation of a novel nested PCR for the routine diagnosis of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). J Feline Med Surg 9:14.
  15. Arjona A, Escolar E, Soto I, et al. 2000. Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects. J Clin Microbiol 38:3448.
  16. Armstrong PJ. 1984. Systemic Serratia marcescens infections in a dog and a cat. J Am Vet Med Assoc 184:1154-1158.
  17. August JR. 1991. Husbandry practices for cats infected with feline leukemia virus or feline immunodeficiency virus. J Am Vet Med Assoc 199:1474-1477.
  18. Babyak SD, Groves MG, Dimski DS, et al. 1996. Evaluation of a saliva test kit for feline leukemia virus antigen. J Am Anim Hosp Assoc 32:397-400.
  19. Bachman D, Cockerell GL, de Noronha F, et al. 1982. Effect of bacille Calmette-Guerin immunotherapy on feline sarcoma virus-induced neoplasms in the cat. Am J Vet Res 43:475-480.
  20. Bandecchi P, Dell’Omodarme M, Magi M, et al. 2006. Feline leukaemia virus (FeLV) and feline immunodeficiency virus infections in cats in the Pisa district of Tuscany, and attempts to control FeLV infection in a colony of domestic cats by vaccination. Vet Rec 158:555.
  21. Banerji N, Kapur V, Kanjilal S. 2007. Association of germ-line polymorphisms in the feline p53 gene with genetic predisposition to vaccine-associated feline sarcoma. J Hered 98:421.
  22. Bangham CR. 1993. Retrovirus infections of the nervous system. Curr Opin Neurol Neurosurg 6:176-181.
  23. Barbacid M, Stephenson JR, Aaronson SA. 1977. Evolutionary relationships between gag gene-coded proteins of murine and primate endogenous type C RNA viruses. Cell 10:641.
  24. Barnett AL, Wensel DL, Li W, et al. 2003. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J Virol 77:2717-2729.
  25. Barr MC. 1996. FIV, FeLV, and FIPV: interpretation and misinterpretation of serological test results. Semin Vet Med Surg Small Anim 11:144-153.
  26. Bauer N, Balzer HJ, Thüre S, et al. 2008. Prevalence of feline haemotropic mycoplasmas in convenience samples of cats in Germany. J Feline Med Surg 10:252.
  27. Bechtel MK, Hayes KA, Mathes LE, et al. 1999. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus. Vet Pathol 36:91-99.
  28. Belgard S, Truyen U, Thibault JC, et al. 2010. Associations between infectious agents and chronic stomatitis in cats. Berl Munch Tierarztl Wochenschr 123:369-376.
  29. Benveniste RE, Sherr CJ, Todaro GJ. 1975. Evolution of type C viral genes: origin of feline leukemia virus. Science 190:886-888.
  30. Blair A, Hayes HM. 1980. Cancer and other causes of death among U.S. veterinarians, 1966-1977. Int J Cancer 25:181-185.
  31. Blanco K, Prendas J, Cortes R et al. 2009. Seroprevalence of viral infections in domestic cats in Costa Rica. J Vet Med Sci 71:661.
  32. Block A, Hartmann K, Lutz H et al. 1997. Placebokontrollierte Doppelblindstudie über die Wirksamkeit eines Paramunitätsinducers bei natürlich FeLV-infizierten Katzen. Tierärztl Prax 25:261.
  33. Boretti FS, Ossent P, Bauer-Pham K, et al. 2004. Recurrence of feline leukemia virus (FeLV) and development of fatal lymphoma concurrent with feline immunodeficiency virus (FIV) induced immune suppression. 7th International Feline Retrovirus Research Symposium Sept 11-15, Pisa, Italy.
  34. Borsberry S. 2002. In-house diagnostic test kits. Vet Rec 150:55.
  35. Brightman AH, Ogilvie GK, Tomkins M. 1991. Ocular disease in FeLV-positive cats: 11 cases (1981-1986). J Am Vet Med Assoc 198:1049-1051.
  36. Bross ID, Gibson R. 1970. Cats and childhood leukemia. J Med 1:180-187.
  37. Brown MA, Cunningham MW, Roca AL, et al. 2008. Genetic characterization of feline leukemia virus from Florida panthers. Emerg Infect Dis 14:252.
  38. Brown MR, Rogers KS. 2001. Neutropenia in dogs and cats: a retrospective study of 261 cases. J Am Anim Hosp Assoc 37:131-139.
  39. 38a. Buchmann AU, Kershaw O, Kempf AJ, et al. 2010. Does a feline leukemia virus infection pave the way for Bartonella henselae infection in cats? J Clin Microbiol 48:3295-3300.
  40. Bunch SE. 1993. Hepatotoxicity associated with pharmacologic agents in dogs and cats. Vet Clin North Am Small Anim Pract 23:659-670.
  41. Bupp K, Sarangi A, Roth MJ. 2006. Selection of feline leukemia virus envelope proteins from a library by functional association with a murine leukemia virus envelope. Virology 351:340.
  42. Caldwell GG, Baumgartener L, Carter C. 1976. Seroepidemiologic testing in man for evidence of antibodies to feline leukemia virus and bovine leukemia virus. Bibl Haematol 43:238-241.
  43. Calia CM, Hohenhaus AE, Fox PR, et al. 1996. Acute tumor lysis syndrome in a cat with lymphoma. J Vet Intern Med 10:409-411.
  44. Cantell K, Pyhala L. 1973. Circulating interferon in rabbits after administration of human interferon by different routes. J Gen Virol 20:97.
  45. Carmichael KP, Bienzle D, McDonnell JJ. 2002. Feline leukemia virus-associated myelopathy in cats. Vet Pathol 39:536-545.
  46. Carroll EE, Dubielzig RR, Schultz RD. 2002. Cats differ from mink and ferrets in their response to commercial vaccines: a histologic comparison of early vaccine reactions. Vet Pathol 39:216-227.
  47. Casey JW, Roach A, Mullins JI, et al. 1981. The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats. Proc Natl Acad Sci USA 78:7778-7782.
  48. Cattori V, Hofmann-Lehmann R. 2008. Absolute quantitation of feline leukemia virus proviral DNA and viral RNA loads by TaqMan real-time PCR and RT-PCR. Methods Mol Biol 429:73.
  49. Cattori V, Pepin AC, Tandon R, et al. 2008. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets. Vet Immunol Immunopathol 123:124.
  50. Cattori V, Tandon R, Pepin A, et al. 2006. Rapid detection of feline leukemia virus provirus integration into feline genomic DNA. Mol Cell Probes 20:172.
  51. Cattori V, Tandon R, Riond B, et al. 2009. The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome. Vet Microbiol 133:292.
  52. Chakrabarti R, Hofman FM, Pandey R, et al. 1994. Recombination between feline exogenous and endogenous retroviral sequences generates tropism for cerebral endothelial cells. Am J Pathol 144:348-358.
  53. Chen H, Bechtel MK, Shi Y, et al. 1998. Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA). J Virol 72:7048.
  54. Clark N, Kushner NN, Barrett CB, et al. 1991. Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection. J Am Vet Med Assoc 199:1433-1443.
  55. Coelho FM, Bomfim MR, de Andrade Caxito F, et al. 2008. Naturally occurring feline leukemia virus subgroup A and B infections in urban domestic cats. J Gen Virol 89:2799.
  56. Cogan DC, Cotter SM, Kitchen LW. 1986. Effect of suramin on serum viral replication in feline leukemia virus-infected pet cats. Am J Vet Res 47:2230-2232.
  57. Collado VM, Gómez-Lucía E, Tejerizo G, et al. 2007. Effect of type I interferons on the expression of feline leukaemia virus. Vet Microbiol 123:180.
  58. Cotter SM. 1983. Treatment of lymphoma and leukaemia with cyclophosphamide, vincristine and prednisolone: II. Treatment of cats. J Am Anim Hosp Assoc 19:166-172.
  59. Cotter SM. 1990. Feline viral neoplasia, pp 316-334. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  60. Cotter SM. 1991. Management of healthy feline leukemia-virus-positive cats. J Am Vet Med Assoc 199:1470-1473.
  61. Cotter SM. 1996. Unpublished data. Tufts University, North Grafton, MA.
  62. Cotter SM. 1997. Changing epidemiology of FeLV. Proceedings of the 15th Annual ACVIM Forum, Lake Buena Vista, FL.
  63. Cotter SM. 1998. Feline viral neoplasia, pp 71-84. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  64. Cotter SM, Hardy WD Jr, Essex M. 1975. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J Am Vet Med Assoc 166:449-454.
  65. Court EA, Watson AD, Peaston AE. 1997. Retrospective study of 60 cases of feline lymphosarcoma. Aust Vet J 75:424-427.
  66. Couto C, Hammer A. 1994. Oncology, pp 755-818. In Sterling RG (ed): The cat diseases and clinical management, ed 2. Churchill Livingstone, New York.
  67. Crighton GW. 1969. Lymphosarcoma in the cat. Vet Rec 84:329-331.
  68. Cullen CL, Haines DM, Jackson ML, et al. 2002. Lack of detection of feline leukemia and feline sarcoma viruses in diffuse iris melanomas of cats by immunohistochemistry and polymerase chain reaction. J Vet Diagn Invest 14:340-343.
  69. Cummins JM, Beilharz MW, Krakowka S, 1999. Oral use of interferon. J Interferon Cytokine Res 19:853.
  70. Cummins JM, Tompkins MB, Olsen RG, et al. 1988. Oral use of human alpha interferon in cats. J Biol Response Mod 7:513-523.
  71. Cunningham MW, Brown MA, Shindle DB, et al. 2008. Epizootiology and management of feline leukemia virus in the Florida puma. J Wildl Dis 44:537.
  72. Daniels MJ, Golder MC, Jarrett O, et al. 1999. Feline viruses in wildcats from Scotland. J Wildl Dis 35:121-124.
  73. Danner RM, Goltz DM, Hess SC, et al. 2007. Evidence of feline immunodeficiency virus, feline leukemia virus, and Toxoplasma gondii in feral cats on Mauna Kea, Hawaii. J Wildl Dis 43:315.
  74. Day MJ, Kyaw-Tanner M, Silkstone MA, et al. 1999. T-cell-rich B-cell lymphoma in the cat. J Comp Pathol 120:155-167.
  75. Day MJ, Schoon HA, Magnol JP, et al. 2007. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine 25:4073.
  76. Day NK, Engelman RW, Liu WT, et al. 1984. Remission of lymphoma leukemia in cats following ex vivo immunosorption therapy using Staphylococcus protein A. J Biol Response Mod 3:278-285.
  77. Day NK, Orf C, Hardy WD, et al. 1980. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats. J Immunol 125:2363-2366.
  78. Dean R, Adams V, Whitbread T, et al. 2006. Study of feline injection site sarcomas. Vet Rec 159:641.
  79. De Clercq E. 1979. Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses. Cancer Lett 8:9-22.
  80. De Man MM, Ducatelle RV. 2007. Bilateral subcutaneous fibrosarcomas in a cat following feline parvo-, herpes- and calicivirus vaccination. J Feline Med Surg 95:432-434.
  81. deMari K, Maynard L, Sanquer A, et al. 2004. Therapeutic effects of recombinant feline interferon-ω on feline leukemia virus (FeLV)-infected and FeLV-feline immunodeficiency virus (FIV) co-infected cats. J Vet Intern Med 18:477-482.
  82. De Noronha F, Poco A, Post JE, et al. 1977. Virus isolation test for feline leukemia virus. J Natl Cancer Inst 58:129-131.
  83. Devauchelle P, Magnol JP. 2001. Dynamik der Entzündungsreaktion bei Katzen induziert nach subkutaner Verabreichung einer nicht adjuvierten Vakzine (abstract). Proceedings of the CNVSPA Congress, Lille, France.
  84. Devauchelle P, Magnol JP. 2001. Dynamique de la réaction inflammatoire induite chez le chat par ládministration sous-cutanée d′un vaccin non adjuvé. Proceedings of the CNVSPA Congress, Lille, France.
  85. Diehl LJ, Hoover EA. 1992. Early and progressive helper T-cell dysfunction in feline leukemia virus-induced immunodeficiency. J Acquir Immune Defic Syndr 5:1188-1194.
  86. Dillon R. 1984. Feline dirofilariasis. Vet Clin North Am Small Anim Pract 14:1185-1199.
  87. Donahue PR, Hoover EA, Beltz GB, et al. 1988. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol 62:722-731.
  88. Dorn CR, Taylor DON, Hibbard HH. 1967. Epizootiologic characteristics of canine and feline leukemia and lymphoma. Am J Vet Res 28:993-1001.
  89. Dorn CR, Taylor DON, Schneider R, et al. 1968. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 40:307-318.
  90. Dorny P, Speybroeck N, Verstraete S, et al. 2002. Serological survey of Toxoplasma gondii, feline immunodeficiency virus and feline leukaemia virus in urban stray cats in Belgium. Vet Rec 151:626-629.
  91. Driciru M, Siefert L, Prager KC, et al. A serosurvey of viral infections in lions (Panthera leo), from Queen Elizabeth National Park, Uganda. J Wildl Dis 42:667, 2006
  92. Dubey JP, Lappin MR, Kwok OC, et al. 2009. Seroprevalence of Toxoplasma gondii and concurrent Bartonella spp., feline immunodeficiency virus, and feline leukemia virus infections in cats from Grenada, West Indies. J Parasitol 95:1129.
  93. Dunham SP, Flynn JN, Rigby MA, et al. 2002. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. Vaccine 20:1483-1496.
  94. Dunham SP, Graham E. 2008. Retroviral infections of small animals. Vet Clin North Am Small Anim Pract 38:879.
  95. Ellis JA, Jackson ML, Bartsch RC, et al. 1996. Use of immunohistochemistry and polymerase chain reaction for detection of leukemia viruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats. J Am Vet Med Assoc 204:767-771.
  96. Elmslie RE, Ogilvie GK, Dow SW, et al. 1991. Evaluation of a biologic response modifier derived from Serratia marcescens: effects on feline macrophages and usefulness for the prevention and treatment of viremia in feline leukemia virus-infected cats. Mol Biother 3:231-238.
  97. Engelman RW, Tyler RD, Trang LQ, et al. 1985. Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A. Am J Pathol 118:367-378.
  98. Englert T, Lutz H, Hartmann K. 2009. Untersuchung des FeLV-Status der süddeutschen Katzenpopulation. Tierärztl Prax 37:A9.
  99. Essex M, Cotter SM, Hardy WD Jr, et al. 1975. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases. J Natl Cancer Inst 55:463-467.
  100. Essex M, Klein G. 1971. Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus. Nature 233:195-196.
  101. Essex M, Sliski AH, Hardy WD Jr, et al. 1976. Immune response to leukemia virus and tumor-associated antigens in cats. Cancer Res 36:640-645.
  102. Essex M, Sliski AH, Hardy WD Jr, et al. 1977. Feline oncornavirus-associated cell membrane antigen: a tumor specific cell surface marker, pp 337-340. In Benvelzen P, Hilgers J, Yohn DS (eds): Advances in comparative leukemia research. Elsevier, Amsterdam.
  103. Essex M, Snyder SP. 1973. Feline oncornavirus-associated cell membrane antigen. I. Serologic studies with kittens exposed to cell-free materials from various feline fibrosarcomas. J Natl Cancer Inst 51:1007-1012.
  104. Ettinger SN. 2003. Principles of treatment for feline lymphoma. Clin Tech Small Anim Pract 18:98-102.
  105. Fails AD, Mitchell TW, Rojko JL, et al. 1997. An oligopeptide of the feline leukemia virus envelope glycoprotein is associated with morphological changes and calcium dysregulation in neuronal growth cones. J Neurovirol 3:179-191.
  106. Faix PH, Feldman SA, Overbaugh J, et al. 2002. Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain. J Virol 76:12369-12375.
  107. Fasal E, Jackson EW, Klauber MR. 1966. Mortality in California veterinarians. J Chron Dis 19:293-306.
  108. Fink MA, Sibal LR, Plata EJ. 1971. Serologic detection of feline leukemia virus antigens or antibodies. J Am Vet Med Assoc 158:1070-1075.
  109. Fisher K. 2001. Providing optimal FeLV maintenance. Vet Pract News 13:30.
  110. Flynn JN, Dunham SP, Watson V, et al. 2002. Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. J Virol 76:2306-2315.
  111. Flynn JN, Hanlon L, Jarrett O. 2000. Feline leukemia virus: protective immunity is mediated by virus specific cytotoxic T lymphocytes. Immunology 101:120-125.
  112. Flynn JN, Hosie MJ, Rigby MA, et al. 2000. Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination. Vaccine 18:1118-1132.
  113. Forman LW, Pal-Ghosh R, Spanjaard RA, et al. 2009. Identification of LTR-specific small non-coding RNA in FeLV infected cells. FEBS Lett 583:1386.
  114. Francis DP, Cotter SM, Hardy WD Jr, et al. 1979. Comparison of virus-positive and virus-negative cases of feline leukemia and lymphoma. Cancer Res 39:3866-3870.
  115. Francis DP, Essex M. 1977. Excretion of feline leukaemia virus by naturally infected pet cats. Nature 269:252-254.
  116. Francis DP, Essex M, Cotter SM, et al. 1981. Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus. Cancer Lett 12:37-42.
  117. Franklin SP, Kays RW, Moreno R, et al. 2008. Ocelots on Barro Colorado Island are infected with feline immunodeficiency virus but not other common feline and canine viruses. J Wildl Dis 44:760.
  118. Fromont E, Pontier D, Langlais M. 2003. Disease propagation in connected host populations with density-dependent dynamics: the case of the feline leukemia virus. J Theor Biol 223:465.
  119. Fromont E, Pontier D, Langlais M. 1998. Dynamics of a feline retrovirus (FeLV) in host populations with variable spatial structure. Proc Biol Sci 265:1097.
  120. Fujino Y, Liao CP, Zhao YS, et al. 2009. Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma. Virology 386:16.
  121. Fujino Y, Ohno K, Tsujimoto H. 2008. Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis. Vet Immunol Immunopathol 123:138.
  122. Fujino Y, Satoh H, Hisasue M, et al. 2003. Detection of the integrated feline leukemia viruses in a cat lymphoid tumor cell line by fluorescence in situ hybridization. J Hered 94:251-255.
  123. Gabor LJ, Jackson ML, Trask B, et al. 2001. Feline leukaemia virus status of Australian cats with lymphosarcoma. Aust Vet J 79:476-481.
  124. Gelain ME, Antoniazzi E, Bertazzolo W, et al. 2006. Chronic eosinophilic leukemia in a cat: cytochemical and immunophenotypical features. Vet Clin Pathol 35:454.
  125. George JW, Rideout BA, Griffey SM, et al. 2002. Effect of preexisting FeLV infection or FeLV and feline immunodeficiency virus coinfection on pathogenicity of the small variant of Haemobartonella felis in cats. Am J Vet Res 63:1172-1178.
  126. Ghosh AK, Bachmann MH, Hoover EA. 1992. Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells. J Virol 66:3707-3714.
  127. Gleich S, Hartmann K. 2009. Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats. J Vet Intern Med 23:552.
  128. Gleich SE, Krieger S, Hartmann K. 2009. Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. J Fel Med Surg 11:985-992.
  129. Gobar GM, Kass PH. 2002. World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J Am Vet Med Assoc 220:1477-1482.
  130. Goldkamp CE, Levy JK, Edinboro CH, et al. 2008. Seroprevalences of feline leukemia virus and feline immunodeficiency virus in cats with abscesses or bite wounds and rate of veterinarian compliance with current guidelines for retrovirus testing. J Am Vet Med Assoc 232:1152.
  131. Gomes-Keller MA, Gönczi E, Grenacher B, et al. 2009. Fecal shedding of infectious feline leukemia virus and its nucleic acids: a transmission potential. Vet Microbiol 134:208.
  132. Gomes-Keller MA, Gönczi E, Tandon R, et al. 2006. Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J Clin Microbiol 44:916.
  133. Gomes-Keller MA, Tandon R, Gönczi E, et al. 2006. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats. Vet Microbiol 112:11.
  134. Grant CK, Harris D, Essex ME, et al. 1980. Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody. J Natl Cancer Inst 64:1527-1533.
  135. Greene CE. 1998. Immunoprophylaxis and immunotherapy, pp 717-750. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  136. Greene CE, Watson ADJ. 1998. Antimicrobial drug formulary, pp 790-919. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia
  137. Griessmayr P, Egberink H, Jarrett O, et al. 2002. Comparison of different new tests for feline immunodeficiency virus and feline leukemia virus infection, p 25. In Abstracts from the 6th International Feline Retrovirus Research Symposium, Amelia Island, FL.
  138. Gruffydd-Jones TJ. 1999. A comparative study on the effects of a canarypox based recombinant leukaemia vaccine (Eurifel FeLV), against a natural FeLV challenge in cats. Proceedings of the 24th World Small Animal Veterinary Association (WSAVA) Congress, Lyon, France.
  139. Guillermo Couto C. 2001. What is new on feline lymphoma? J Feline Med Surg 3:171-176.
  140. Guimaraes AM, Brandão PE, de Moraes W, et al. 2009. Survey of feline leukemia virus and feline coronaviruses in captive neotropical wild felids from Southern Brazil. J Zoo Wildl Med 40:360.
  141. Gutenson N, Essex M, Francis DP. 1980. Risk to humans from exposure to feline leukemia virus: epidemiological considerations. Viruses in naturally occurring cancers, p 7. In Proceedings of the Cold Spring Harbor Conference on Cell Proliferation, New York.
  142. Gwynn SR, Hankenson FC, Lauring AS, et al. 2000. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains. J Virol 74:5754-5761.
  143. Haney SM, Beaver L, Turrel J, et al. 2009. Survival analysis of 97 cats with nasal lymphoma: a multi-institutional retrospective study (1986-2006). J Vet Intern Med 23:287.
  144. Hanlon L, Argyle D, Bain D, et al. 2001. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol 75:8424-8433.
  145. Harbour DA, Gunn-Moore DA, Gruffydd-Jones TJ, et al. 2002. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. Vaccine 20:2866-2872.
  146. Hardy WD Jr. 1978. Epidemiology of primary neoplasms of lymphoid tissues in animals, pp 129-180. In Twomey JJ, Good RA (eds): Comprehensive immunology of lymphoreticular neoplasms. Plenum Medical Book Company, New York.
  147. Hardy WD Jr. 1981. Hematopoietic tumors of cats. J Am Anim Hosp Assoc 17:921-940.
  148. Hardy WD Jr. 1981. The feline leukemia virus. J Am Anim Hosp Assoc 17:951-980.
  149. Hardy WD Jr. 1982. Immunopathology induced by the feline leukemia virus. Springer Semin Immunopathol 5:75-105.
  150. Hardy WD Jr. 1991. General principles of retrovirus immunodetection tests. J Am Vet Med Assoc 10:1282-1286.
  151. Hardy WD Jr, Hirshaut Y, Hess P. 1973. Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. Unifying concepts of leukemia. Bibl Haemat 39:778-799.
  152. Hardy WD Jr, MacEwen EG. 1989. Hematopoietic tumors, pp 362-411. In Withrow SJ, MacEwen EG (eds): Clinical veterinary oncology. JB Lippincott, Philadelphia.
  153. Hardy WD Jr, McClelland AJ, Zuckermann EE, et al. 1980. Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV. Nature 288:90-92.
  154. Hardy WD Jr, Zuckerman EE. 1991. Ten-year study comparing enzyme-linked immunosorbent assay with the immunofluorescent antibody test for detection of feline leukemia virus infection in cats. J Am Vet Med Assoc 199:1365-1373.
  155. Hardy WD Jr, Zuckerman EE, MacEwen EG, et al. 1977. A feline leukaemia and sarcoma virus-induced tumor-specific antigen. Nature 270:249-251
  156. Hardy WD Jr, Zuckerman EE, MacEwen EG, et al. 1977. FeLV- and FeSV-induced tumor-specific antigen. Nature 270:249.
  157. Harper HD, Sjoquist J, Hardy WD Jr, et al. 1985. Antitumor activity of protein A administered intravenously to pet cats with leukemia or lymphosarcoma. Cancer 55:1863-1867.
  158. 156a. Harrison TM, McKnight CA, Sikarskie JG, et al. 2010. Malignant lymphoma in African lions (Panthera leo). Vet Pathol 47:952-957.
  159. Harrus S, Klement E, Aroch I. 2002. Retrospective study of 46 cases of feline haemobartonellosis in Israel and their relationships with FeLV and FIV infections. Vet Rec 151:82-85.
  160. Hartmann K. 1995. AZT in the treatment of feline immunodeficiency virus infection: part 1. Feline Pract 23:16-21.
  161. Hartmann K. 1995. AZT in the treatment of feline immunodeficiency virus infection: part 2. Feline Pract 23:13-20.
  162. Hartmann K. 2005. FeLV treatment strategies and prognosis. Suppl Compend Cont Educ Pract Vet 27:14.
  163. Hartmann K. 2005. Pathogenesis of FeLV. Suppl Compend Cont Educ Pract Vet 27:8.
  164. Hartmann K. 2008. Feline leukemia virus and feline immunodeficiency virus, p 1278. In Bonagura JD, Twedt DC (eds): Kirk's current veterinary therapy XIV. Elsevier, St Louis.
  165. Hartmann K, Block A, Ferk G, et al. 1998. Treatment of feline leukemia virus-infected cats with paramunity inducer. Vet Immunol Immunopathol 65:267-275.
  166. Hartmann K, Block A, Ferk G, et al. 1999. Treatment of feline leukemia virus (FeLV) infection. Vet Microbiol 69:111-113.
  167. Hartmann K, Brunner K, Lutz H. 2002. Treatment of feline leukemia virus infection with 3-azido-2,3-dideoxythymidine and human alpha-interferon, p 779. In Proceedings of the 20th Annual ACVIM Forum, Dallas.
  168. Hartmann K, Donath A, Beer B, et al. 1992. Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol 35:167-175.
  169. Hartmann K, Gerle K, Leutenegger C, et al. 1998. Feline leukemia virus-most important oncogene in cats? p 39. In Abstracts from the 4th International Fel ine Retrovirus Reseach Symposium, Glasgow, Scotland, UK.
  170. Hartmann K, Griessmayr P, Schulz B, et al. 2007. Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection. J Feline Med Surg 9:439.
  171. Hartmann K, Schulz B, Hirschberger J. 2002. Hypereosinophiles Syndrom bei der Katze—zwei Fälle. Tierärztl Prax 20:445.
  172. Hartmann K, Werner RM, Egberink H, et al. 2001. Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet Rec 149:317-320.
  173. Hawkins EC. 1991. Saliva and tear tests for feline leukemia virus. J Am Vet Med Assoc 199:1382-1385.
  174. Hawkins EC, Johnson L, Pedersen NC, et al. 1986. Use of tears for diagnosis of feline leukemia virus infection. J Am Vet Med Assoc 188:1031.
  175. Hawks DM, Legendre AM, Rohrbach BW. 1991. Comparison of four test kits for feline leukemia virus antigen. J Am Vet Med Assoc 199:1373-1376.
  176. Hayes KA, Rojko JL, Mathes LE. 1992. Incidence of localized feline leukemia virus infection in cats. Am J Vet Res 53:604-607.
  177. Hayes KA, Rojko JL, Tarr MJ, et al. 1989. Atypical localised viral expression in a cat with feline leukaemia. Vet Rec 124:344.
  178. 175a. Helfer-Hungerbuehler AK, Cattori V, Boretti FS, et al. 2010. Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma. Retrovirology 7:14.
  179. Hendrick MJ, Goldschmidt MH, Shofer FS, et al. 1992. Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Res 52:5391-5394.
  180. Hendrick MJ, Shofer FS, Goldschmidt MH, et al. 1994. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J Am Vet Med Assoc 205:1425-1429.
  181. Herring ES, Troy GC, Toth TE, et al. 2001. Detection of feline leukaemia virus in blood and bone marrow of cats with varying suspicion of latent infection. J Feline Med Surg 3:133-141.
  182. Herring IP, Troy GC, Toth TE, et al. 2001. Feline leukemia virus detection in corneal tissues of cats by polymerase chain reaction and immunohistochemistry. Vet Ophthalmol 4:119-126.
  183. Hill SL, Cheney JM, Taton-Allen GF, et al. 2000. Prevalence of enteric zoonotic organisms in cats. J Am Vet Med Assoc 216:687-692.
  184. Hines DL, Cutting JA, Dietrich DL, et al. 1991. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection. J Am Vet Med Assoc 199:1428-1430.
  185. Hisasue M, Nagashima N, Nishigaki K, et al. 2009. Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat. Int J Cancer 124:1133.
  186. Hisasue M, Nishigaki K, Katae H, et al. 2000. Clonality analysis of various hematopoietic disorders in cats naturally infected with feline leukemia virus. J Vet Med Sci 62:1059-1065.
  187. Hisasue M, Okayama H, Okayama T, et al. 2001. Hematologic abnormalities and outcome of 16 cats with myelodysplastic syndrome. J Vet Intern Med 15:471-477.
  188. Hoffmann-Fezer G, Mortelbauer W, Hartmann K, et al. 1996. Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus. Res Vet Sci 61:222-226.
  189. Hofmann-Lehmann R, Cattori V, Tandon R, et al. 2007. Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up. Vaccine 25:5531.
  190. Hofmann-Lehmann R, Cattori V, Tandon R, et al. 2008. How molecular methods change our views of FeLV infection and vaccination. Vet Immunol Immunopathol 123:119.
  191. Hofmann-Lehmann R, Holznagel E, Ossent P. 1997. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections. Hematology, clinical chemistry, and lymphocyte subsets. Clin Diagn Lab Immunol 4:33-42.
  192. Hofmann-Lehmann R, Huder JB, Gruber S, et al. 2001. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J Gen Virol 82:1589-1596.
  193. Hoover EA, Kociba GJ, Hardy WD Jr, et al. 1974. Erythroid hypoplasia in cats inoculated with feline leukemia virus. J Natl Cancer Inst 53:1271-1276.
  194. Hoover EA, Mullins JI. 1991. Feline leukemia virus infection and diseases. J Am Vet Med Assoc 199:1287-1297.
  195. Hoover EA, Mullins JI, Chu H-J, et al. 1995. Development and testing of an inactivated feline leukemia virus vaccine. Semin Vet Med Surg Small Anim 10:238-243.
  196. Hoover EA, Mullins JI, Quackenbush SL, et al. 1987. Experimental transmission and pathogenesis of immunodeficiency syndrome in cats. Blood 70:1880-1882.
  197. Hoover EA, Olsen RG, Hardy WD Jr, et al. 1976. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J Natl Cancer Inst 57:365-369.
  198. Hoover EA, Perigo NA, Quackenbush SL, et al. 1991. Protection against feline leukemia virus infection by use of an inactivated virus vaccine. J Am Vet Med Assoc 199:1392-1401.
  199. Hoover EA, Schaller JP, Mathes LE, et al. 1977. Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated. Infect Immun 16:54.
  200. Hoover EA, Zeidner NS, Perigo NA, et al. 1989. Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy. Intervirology 30:12-25.
  201. Hörber D, Mayr B. 1991. Paramunization of FeLV-positive cats with PIND-AVI. Tierärztl Prax 19:311-313.
  202. Hosie MJ, Dunsford T, Klein D, et al. 2000. Vaccination with inactivated virus but not viral DNA reduces virus load flowing challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol 74:9403-9411.
  203. Hosie MJ, Jarrett O. 1999. Analysis of the protective immunity induced by feline immunodeficiency virus vaccination. Adv Vet Med 41:325-332.
  204. Hosie MJ, Robertson C, Jarrett O. 1989. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec 125:293.
  205. Huisman W, Karlas JA, Siebelink KH, et al. 1998. Feline immunodeficiency virus subunit vaccines that induce virus neutralizing antibodies but no protection against challenge infection. Vaccine 16:181-187.
  206. Ishida T, Uchino T. 1995. Use of feline recombinant interferon in feline viral diseases, pp 430-431. In Proceedings of the World Veterinary Congress, September 3-9, Yokohama Japan.
  207. Jackson ML, Haines DM, Meric SM, et al. 1993. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma. Can J Vet Res 57:269-276.
  208. Jackson ML, Haines DM, Misra V. 1996. Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases. Vet Microbiol 53:213-225.
  209. Jackson ML, Haines DM, Taylor SM, et al. 1996. Feline leukemia virus detection by ELISA and PCR in peripheral blood from 68 cats with high, moderate, or low suspicion of having FeLV-related disease. J Vet Diagn Invest 8:25-30.
  210. Jackson ML, Wood SL, Misra V, et al. 1996. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age. Can J Vet Res 60:199-204.
  211. Jacquemin PC, Saxinger C, Gallo RC. 1978. Surface antibodies of human myelogenous leukaemia leukocytes reactive with specific type-C viral reverse transcriptases. Nature 276:230-236.
  212. Jarrett O. 1995. Detection of FeLV antigen. Vet Rec 137:127.
  213. Jarrett O. 2001. Feline leukaemia virus neutralizing antibodies. Vet Rec 149:632.
  214. Jarrett O. 2003. Strategies for successful FeLV vaccination. In Proceedings of the WSAVA Congress, Oct 24-27, Bangkok, Thailand.
  215. Jarrett O, Golder MC, Steward MF. 1982. Detection of transient and persistent feline leukaemia virus infections. Vet Rec 110:225-228.
  216. Jarrett O, Laird HM, Hay D, et al. 1968. Replication of cat leukaemia virus in cell cultures. Nature 219:521-522.
  217. Jarrett O, Laird HM, Hay D. 1969. Growth of feline leukaemia virus in human cells. Nature 224:1208-1209.
  218. Jarrett O, Laird HM, Hay D. 1973. Determinants of the host range of feline leukemia viruses. J Gen Virol 20:169-175.
  219. Jarrett O, Pacitti AM, Hosie MJ, et al. 1991. Comparison of diagnostic methods for feline leukemia virus and feline immunodeficiency virus. J Am Vet Med Assoc 1991:1362-1364.
  220. Jarrett O, Russel PH. 1978. Differential growth and transmission in cats of feline leukemia viruses of subgroups A and B. Int J Cancer 21:466-472.
  221. Jarrett WFH, Crawford EM, Martin WB, et al. 1964. A virus-like particle associated with leukemia (lymphosarcoma). Nature 202:567-568.
  222. Jarrett WFH, Martin WB, Crighton GW, et al. 1964. Transmission experiments with leukemia (lymphosarcoma). Nature 202:566-567.
  223. 219a. Jirjis FF, Davis T, Lane J, et al. 2010. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine. Vet Therap 11:E1-E6.
  224. Jones FR, Grant CK, Snyder HW Jr. 1984. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments. J Biol Response Mod 3:286-292.
  225. Kahler SC. 2002. Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners. J Am Vet Med Assoc 221:1231-1234.
  226. Kanellos T, Sutton DJ, Salisbury CF, et al. 2008. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens. J Feline Med Surg 10:346.
  227. Karlas JA, Siebelink KH, Peer MA, et al. 1999. Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection. J Gen Virol 80:761-765.
  228. Karlas JA, Siebelink KH, v Peer MA, et al. 1998. Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells. Vet Immunol Immunopathol 65:353-365.
  229. Kass PH, Barnes WG, Spangler WL, et al. 1993. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 203:396-405.
  230. Kass PH, Spangler WL, Hendrick MJ, et al. 2003. Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 223:1283-1292.
  231. Kerr MG. 2002. Testing for FeLV and FIV infection. Vet Rec 150:28.
  232. Kerr MG, Smith KJD. 1995. Detection of FeLV antigen by indirect immunofluorescence in ELISA/CITE negative cats. Vet Rec 136:516-518.
  233. Kidney BA, Ellis JA, Haines DM, et al. 2001. Comparison of endogenous feline leukemia virus RNA content in feline vaccine and nonvaccine site-associated sarcomas. Am J Vet Res 62:1990-1994.
  234. Kipar A, Kremendahl J, Grant CK, et al. 2000. Expression of viral proteins in feline leukemia virus-associated enteritis. Vet Pathol 37:129-136.
  235. Kipar A, Kremendahl J, Jackson ML, et al. 2001. Comparative examination of cats with feline leukemia virus-associated enteritis and other relevant forms of feline enteritis. Vet Pathol 38:359-371.
  236. Kirpensteijn J. 2006. Feline injection site-associated sarcoma: is it a reason to critically evaluate our vaccination policies? Vet Microbiol 117:59.
  237. Kiselow MA, Rassnick KM, McDonough SP, et al. 2008. Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005). J Am Vet Med Assoc 232:405.
  238. Kitchen LW, Mather FJ. 1989. Hematologic effects of short-term oral diethylcarbamazine treatment given to chronically feline leukemia virus-infected cats. Cancer Lett 45:183-187.
  239. Kitchen LW, Mather FJ, Cotter SM. 1988. Effect of continuous oral diethylcarbamazine treatment on lymphocyte counts of feline leukemia virus-infected cats. J Clin Lab Immunol 27:179-181.
  240. Koech DK, Obel AO. 1990. Efficacy of Kemron (low dose oral natural human interferon alpha) in the management of HIV-1 infection and acquired immune deficiency syndrome (AIDS). East Afr Med J 67:64.
  241. Kohn B, Weingart C, Eckmann V, et al. 2006. Primary immune-mediated hemolytic anemia in 19 cats: diagnosis, therapy, and outcome (1998-2004). J Vet Intern Med 20:159.
  242. Koshy R, Wong-Staal R, Gallo RC, et al. 1979. Distribution of feline leukemia virus DNA sequences in tissues of normal and leukemic domestic cats. Virology 99:135-144.
  243. Kraft W, Kuffer M. 1995. Treatment of severe neutropenias in dogs and cats with filgrastim. Tierarztl Prax 23:609-613.
  244. Krick EL, Little L, Patel R, et al. 2008. Description of clinical and pathological findings, treatment and outcome of feline large granular lymphocyte lymphoma (1996-2004). Vet Comp Oncol 6:102.
  245. Kristal O, Lana SE, Ogilvie GK, et al. 2001. Single agent chemotherapy with doxorubicin for feline lymphoma: a retrospective study of 19 cases (1994-1997). J Vet Intern Med 15:125-130.
  246. Kyle KN, Wright Z. 2010. Apparent feline leukemia virus-induced chronic lymphocytic leukemia and response to treatment. J Fel Med Surg 12:341-344.
  247. Laberke S, Hartmann K. 2009. Differenzialdiagnostische Aspekte und Charakterisierung der Anämie bei 79 Katzen unter besonderer Berücksichtigung der Rolle von Infektionen mit felinen Hämoplasmen. Tierärztl Prax 37:33.
  248. Laberke S, Just F, Pfister K, et al. 2010. Prevalence of feline haemotrophic Mycoplasma spp. in cats in Southern Bavaria, Germany, and risk factor analysis for infection. Berl Munch Tierarztl Wochenschr 123:42-48.
  249. Lafrado LJ. 1994. Evaluation of a feline leukemia virus vaccine in a controlled natural transmission study. J Am Vet Med Assoc 204:914-917.
  250. Lafrado JL, Mathes LE, Zack PM, et al. 1990. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection. Am J Vet Res 51:482.
  251. Lane SB, Kornegay JN, Duncan JR, et al. 1994. Feline spinal lymphosarcoma: a retrospective evaluation of 23 cats. J Vet Intern Med 8:99-104.
  252. Langhammer S, Hübner J, Kurth R, et al. 2006. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E. Immunology 117:229.
  253. Lappin MR. 1995. Opportunistic infections associated with retroviral infections in cats. Semin Vet Med Surg 10:244-250.
  254. Lauring AS, Anderson MM, Overbaugh J. 2001. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J Virol 75:8888-8898.
  255. Lauring AS, Cheng HH, Eiden MV, et al. 2002. Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection. J Virol 76:8069-8078.
  256. Lee IT, Levy JK, Gorman SP, et al. 2002. Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats. J Am Vet Med Assoc 220:620-622.
  257. Legendre AM, Hawks DM, Sebring R, et al. 1991. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure. J Am Vet Med Assoc 199:1456-1462.
  258. Legendre AM, Mitchner KL, Potgieter LND. 1990. Efficacy of a feline leukemia virus vaccine in a natural exposure challenge. J Vet Intern Med 4:92-98.
  259. Levy J, Richards J, Edwards D, et al. 2001. Feline retrovirus testing and management. Compend Cont Educ Pract Vet 22:652-657.
  260. Levy J, Richards J, Edwards D, et al. 2003. 2001 Report of the American Association of Feline Practitioners and Academy of Feline Medicine Advisory Panel on feline retrovirus testing and management. J Feline Med Surg 5:3-10.
  261. Levy JK. 2000. FeLV and non-neoplastic FeLV-related disease, pp 424-432. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine. WB Saunders, Philadelphia.
  262. Levy LS. 2008. Advances in understanding molecular determinants in FeLV pathology. Vet Immunol Immunopathol 123:14.
  263. Levy JK, Crawford PC. 2005. Feline leukemia virus, p. 653. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine, ed 2. WB Saunders, Philadelphia.
  264. Levy J, Crawford C, Hartmann K, et al. 2008. 2008 American Association of Feline Practitioners’ feline retrovirus management guidelines. J Feline Med Surg 10:300.
  265. Levy JK, Crawford PC, Lappin MR, et al. 2008. Infectious diseases of dogs and cats on Isabela Island, Galapagos. J Vet Intern Med 22:60.
  266. Levy JK, Edinboro CH, Glotfelty CS, et al. 2007. Seroprevalence of Dirofilaria immitis, feline leukemia virus, and feline immunodeficiency virus infection among dogs and cats exported from the 2005 Gulf Coast hurricane disaster area. J Am Vet Med Assoc 231:218.
  267. Levy JK, Lorentzen L, Shields J, et al. 2006. Long-term outcome of cats with natural FeLV and FIV infection. 8th International Feline Retrovirus Research Symposium, Washington, DC, Oct 8-11.
  268. Levy JK, Scott HM, Lachtara JL, et al. 2006. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J Am Vet Med Assoc 228:371.
  269. Lies M. 1990. Volume of opinion warrants merit. Vet Forum 6:42.
  270. Linenberger ML, Abkowitz JL. 1992. In vivo infection of marrow fibroblasts by feline leukemia virus. Exp Hematol 20:1022-1027.
  271. Linenberger ML, Deng T. 1999. The effects of feline retroviruses on cytokine expression. Vet Immunol Immunopathol 72:343-368.
  272. Linenberger ML, Dow SW, Abkowity JL. 1995. Feline leukemia virus infection downmodulates the production of growth-inhibitory activity by marrow stromal cells. Exp Hematol 23:1069-1079.
  273. Little S, Sears W, Lachtara J, et al. 2009. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in Canada. Can Vet J 50:644.
  274. Liu WT, Engelman RW, Trang LQ, et al. 1984. Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia. Proc Natl Acad Sci USA 81:3516-3520.
  275. Liu WT, Good RA, Trang LQ, et al. 1984. Remission of leukemia and loss of feline leukemia virus in cats injected with Staphylococcus protein A: association with increased circulating interferon and complement-dependent cytotoxic antibody. Proc Natl Acad Sci USA 81:6471-6647.
  276. Loar AS. 1987. The zoonotic potential of feline leukemia virus. Vet Clin North Am Small Anim Pract 17:105-115.
  277. Lopez NA, Jacobson RH. 1989. False-positive reactions associated with anti-mouse activity in serotests for feline leukemia virus antigen. J Am Vet Med Assoc 195:741-746.
  278. Lopez NA, Jacobson RH, Scarlett JM, et al. 1989. Sensitivity and specificity of blood test kits for feline leukemia virus antigen. J Am Vet Med Assoc 195:747-751.
  279. Lorimer HE. 1999. Hereditary lymphosarcoma in oriental shorthair cats. Feline Pract (Suppl 29).
  280. Lott-Stolz G. 1988. Osteochondromatosis in the cat. Schweiz Archiv Tierheilkd 130:635-638.
  281. Louwerens M, London CA, Pedersen NC, et al. 2005. Feline lymphoma in the post-feline leukemia virus era. J Vet Intern Med 19:329.
  282. Luaces I, Doménech A, García-Montijano M, et al. 2008. Detection of feline leukemia virus in the endangered Iberian lynx (Lynx pardinus). J Vet Diagn Invest 20:381.
  283. Lutz H, Addie D, Belák S, et al. 2009. Feline leukaemia. ABCD guidelines on prevention and management. J Feline Med Surg 11:565.
  284. Lutz H, Castelli I, Ehrensperger F, et al. 1995. Panleukopenia-like syndrome of FeLV caused by co-infection with FeLV and feline panleukopenia virus. Vet Immunol Immunopathol 46:21-33.
  285. Lutz H, Jarrett O. 1987. Detection of feline leukemia virus infection in saliva. J Clin Microbiol 25:827.
  286. Lutz H, Pedersen NC, Durbin R, et al. 1983. Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. J Immunol Methods 56:209-220.
  287. Lutz H, Pedersen N, Higgins J, et al. 1980. Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus. Cancer Res 40:3642.
  288. Macieira DB, de Menezes Rde C, Damico CB, et al. 2008. Prevalence and risk factors for hemoplasmas in domestic cats naturally infected with feline immunodeficiency virus and/or feline leukemia virus in Rio de Janeiro, Brazil. J Feline Med Surg 10:120.
  289. Macy DW. 1991. Testing cats for feline leukemia virus. Vet Med Mar:278-288.
  290. Macy DW. 1995. The potential role and mechanisms of FeLV vaccine-induced neoplasms. Semin Vet Med Surg 10:234-237.
  291. Macy DW. 1999. Current understanding of vaccination site-associated sarcomas in the cat. J Feline Med Surg 1:15-21.
  292. Macy DW, Chretin J. 1999. Local postvaccinal reactions of a recombinant rabies vaccine. Vet Forum 8:44-49.
  293. Madewell BR, Griffey SM, McEntee MC, et al. 2001. Feline vaccine-associated fibrosarcoma: an ultrastructural study of 20 tumors (1996-1999). Vet Pathol 38:196-202.
  294. Madewell BR, Jarrett O. 1983. Recovery of feline leukaemia virus from non-viraemic cats. Vet Rec 112:339-342.
  295. Mahony OM, Moore AS, Cotter SM, et al. 1995. Alimentary lymphoma in cats: 28 cases (1988-1993). J Am Vet Med Assoc 207:1593-1598.
  296. Major A, Cattori V, Boenzli E, et al. 2010. Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection. Vet Res 41:17.
  297. Malik R, Gabor LJ, Foster SF, et al. 2001. Therapy for Australian cats with lymphosarcoma. Aust Vet J 79:808-817.
  298. Marker L, Munson L, Basson PA, et al. 2003. Multicentric T-cell lymphoma associated with feline leukemia virus infection in a captive Namibian cheetah (Acinonyx jubatus). J Wildl Dis 39:690-695.
  299. Martín-Sánchez J, Acedo C, Muñoz-Pérez M, et al. 2007. Infection by Leishmania infantum in cats: epidemiological study in Spain. Vet Parasitol 145:267.
  300. Maruyama S, Kabeya H, Nakao R, et al. 2003. Seroprevalence of Bartonella henselae, Toxoplasma gondii, FIV and FeLV infections in domestic cats in Japan. Microbiol Immunol 47:147-153.
  301. Mathes LE, Polas PJ, Hayes KA, et al. 1992. Pre- and postexposure chemoprophylaxis: evidence that 3′-azido-3′-dideoxythymidine inhibits feline leukemia virus disease by drug-induced vaccine response. Antimicrob Agents Chemother 36:2715-2721.
  302. Matsumoto Y, Momoi Y, Watari T, et al. 1992. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology 189:745-749.
  303. Mauldin GE, Mooney SC, Meleo RE, et al. 1995. Chemotherapy in 132 cats with lymphoma:1988-1994, pp 35-36. In Proceedings of the Veterinary Cancer Society.
  304. Maynard L, De Mari K, Lebreux B. 2000. Efficacy of a recombinant feline omega interferon in the treatment of symptomatic FeLV- or FeLV- and FIV-positive cats, p 122a. In Proceedings of the 10th Congress of the ESVIM, Neuchâtel, Switzerland.
  305. McCaw D. 1995. Caring for the retrovirus infected cat. Semin Vet Med Surg 10:216-219.
  306. McCaw DL, Boon GD, Jergens AE, et al. 1998. Immunomodulation therapy for FeLV: a comparison of two agents, abstract #127. American College of Veterinary Internal Medicine.
  307. McCaw DL, Boon GD, Jergens AE, et al. 2001. Immunomodulation therapy for feline leukemia virus infection. J Am Anim Hosp Assoc 37:356-363.
  308. McNiel EA. 2001. Vaccine-associated sarcomas in cats: a unique cancer model. Clin Orthop Jan(382):21-27.
  309. Megid J, Kaneno R. 2000. Natural killer activity in mice infected with rabies virus and submitted to P. acnes (Propionibacterium acnes) as immunomodulator. Comp Immunol Microbiol Infect Dis 23:91-97.
  310. Meli ML, Cattori V, Martínez F, et al. 2009. Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One 4:e4744.
  311. Mendes-de-Almeida F, Labarthe N, Guerrero J, et al. 2007. Follow-up of the health conditions of an urban colony of free-roaming cats (Felis catus Linnaeus, 1758) in the city of Rio de Janeiro, Brazil. Vet Parasitol 147:9.
  312. Mendoza R, Anderson MM, Overbaugh J. 2006. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J Virol 80:3378.
  313. Miró G, Doménech A, Escolar E, et al. 2007. Plasma electrophoretogram in feline immunodeficiency virus (FIV) and/or feline leukaemia virus (FeLV) infections. J Vet Med A Physiol Pathol Clin Med 54:203.
  314. Mitchell TW, Rojko JL, Hartke JR, et al. 1997. FeLV envelope protein (gp70) variable region 5 causes alterations in calcium homeostasis and toxicity of neurons. J Acquir Immune Defic Syndr Hum Retrovirol 14:307-320.
  315. Miyazawa T. 2002. Infections of feline leukemia virus and feline immunodeficiency virus. Front Biosci 7:d504-d518.
  316. Miyazawa T, Jarrett O. 1997. Feline leukaemia virus proviral DNA detected by polymerase chain reaction in antigenaemic but non-viraemic ("discordant") cats. Arch Virol 142:323-332.
  317. Mooney SC, Hayes AA, MacEwen EG, et al. 1989. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981). J Am Vet Med Assoc 194:696-699.
  318. Moore AS, Cotter SM, Frimberger AE, et al. 1996. A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma. J Vet Intern Med 10:372-375.
  319. Morgan RA, Dornsife RE, Anderson WF, et al. 1993. In vitro infection of human bone marrow by feline leukemia viruses. Virology 193:439-442.
  320. Morrison JA. 2001. Erythremic myelosis. Compendium 23:880-885.
  321. Moser M, Burns CC, Boomer S, et al. 1998. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors. Virology 242:366-377.
  322. Muirden A. 2002. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus and feline coronavirus in stray cats sent to an RSPCA hospital. Vet Rec 150:621-625.
  323. Munday JS, Stedman NL, Richey LJ. 2003. Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas. Vet Pathol 40:288.
  324. Mylonakis ME, Petanides TA, Valli VE, et al. 2008. Acute myelomonocytic leukaemia with short-term spontaneous remission in a cat. Aust Vet J 86:224.
  325. Nagashima N, Hisasue M, Higashi K, et al. 2001. Bone marrow colony-forming unit assay in cats with naturally occurring myelodysplastic syndromes. Int J Hematol 73:453-456.
  326. Nakata R, Miyazawa T, Shin YS, et al. 2003. Reevaluation of host ranges of feline leukemia virus subgroups. Microbes Infect 5:947-950.
  327. Neil JC, Hughes D, McFarlane R, et al. 1984. Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature 308:814-820.
  328. Nelson P, Sellon R, Novotney C, et al. 1995. Therapeutic effects of diethylcarbamazine and 3′-azido-3′-deoxythymidine on feline leukemia virus lymphoma formation. Vet Immunol Immunopathol 46:181-194.
  329. Nishigaki K, Okuda M, Endo Y, et al. 1997. Structure and function of the long terminal repeats of feline leukemia viruses derived from naturally occurring acute myeloid leukemias in cats. J Virol 71:9823-9827.
  330. Nowotny N, Uthman A, Haas OA, et al. 1995. Is it possible to catch leukemia from a cat? Lancet 346:252-253.
  331. 326a. Oohashi E, Yamada K, Oohashi M, et al. 2009. Chronic progressive polyarthritis in a femal cat. J Vet Med Sci 72:511-514.
  332. O’Connor TP Jr, Tonelli QJ, Scarlett JM. 1991. Report of the National FeLV/FIV Awareness Project. J Am Vet Med Assoc 199:1348-1352.
  333. Ogilvie GK. 1995. Hematopoietic growth factors: frontiers for cure. Vet Clin North Am Small Anim Pract 25:1441-1456.
  334. Ogilvie GK, Moore AS. 1995. Managing the veterinary cancer patient. Veterinary Learning Systems, Trenton, NJ.
  335. Ogilvie GK, Tompkins MB, et al. 1988. Clinical and immunologic aspects of FeLV-induced immunosuppression. Vet Microbiol 17:287-296.
  336. Olsen RG, Mathes LE, Yohn DS. 1975. Complement-fixation-inhibition as a test for antibodies in cats and humans to C-type RNA tumor virus antigen. Bibl Haematol 40:419-429.
  337. O’Rourke K. 2002. Progress made in feline sarcoma research. J Am Vet Med Assoc 220:734.
  338. Overbaugh J, Donahue PR, Quackenbush SL, et al. 1988. Molecular cloning of a feline leukemia virus that induce fatal immunodeficiency disease in cats. Science 239:906-910.
  339. Pacitti AM, Jarrett O. 1985. Duration of the latent state in feline leukaemia virus infections. Vet Rec 117:472-474.
  340. Pacitti AM, Jarrett O, Hay D. 1986. Transmission of feline leukaemia virus in the milk of a non-viraemic cat. Vet Rec 118:381.
  341. Pan J, Zhong C, Chang Z, et al. 2003. A potential therapeutic strategy to combat leukemia virus infection. Cancer Biol Ther 2:92-99.
  342. Pardi D, Hoover EA, Quackenbush SL, et al. 1991. Selective impairment of humoral immunity in feline leukemia virus-induced immunodeficiency. Vet Immunol Immunopathol 28:183-200.
  343. Pedersen NC. 1988. Feline leukemia virus infection, p 83. In Pedersen NC (ed): Feline infectious diseases. American Veterinary Publications, Santa Barbara, CA.
  344. Pedersen NC. 1991. Feline leukemia virus infection, pp 210-220. In Pedersen NC (ed): Feline husbandry, diseases and management in the multiple cat environment. American Veterinary Publications, Goleta, CA.
  345. Pedersen NC, Meric SM, Ho E, et al. 1984. The clinical significance of latent feline leukemia virus infection in cats. Feline Pract 14:32-48.
  346. Pedersen NC, Theilen G, Keane MA, et al. 1977. Studies of naturally transmitted feline leukemia virus infection. Am J Vet Res 38:1523.
  347. Penrose M. 1970. Cat leukemia. Br Med J 1:755.
  348. Pepin AC, Tandon R, Cattori V, et al. 2007. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats. Virus Res 127:9.
  349. Phipps AJ, Hayes KA, Al-dubaib M, et al. 2000. Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B. Virology 277:40-47.
  350. Pinches MD, Diesel G, Helps CR, et al. 2007. An update on FIV and FeLV test performance using a Bayesian statistical approach. Vet Clin Pathol 36:141.
  351. Pinches MD, Helps CR, Gruffydd-Jones TJ, et al. 2007. Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. J Feline Med Surg 9:8.
  352. Piscopo SE. 2000. Feline retroviruses and the skin. Vet Forum Jan:32-40.
  353. 347a. Polani S, Roca L, Rosensteel BB, et al. 2010. Evolutionary dynamics of endogenous feline leukemia virus proliferation among species of the domestic cat lineage. Virology 405:397-407.
  354. Polas PJ, Swenson CL, Sams R, et al. 1990. In vitro and in vivo evidence that the antiviral activity of 2′,3′-dideoxycytidine is target cell dependent in a feline retrovirus animal model. Antimicrob Agents Chemother 34:1414-1421.
  355. Pollock RVH, Scarlett JM. 1990. Randomized blind trial of a commercial FeLV vaccine. J Am Vet Med Assoc 196:611-616.
  356. Pool RR, Carrig CB. 1972. Multiple cartilagenous exostoses in a cat. Vet Pathol 9:350-359.
  357. Post JE, Warren L. 1980. Reactivation of latent feline leukemia virus, p. 151. In Hardy WD, Essex M, McClelland AJ (eds): Feline leukemia virus. Elsevier North Holland, New York.
  358. Poulet H, Brunet S, Boularand C, et al. 2003. Efficacy of a canarypox virus-vectored vaccine against feline leukaemia. Vet Rec 153:141-145.
  359. Prihirunkit K, Narkkong NA, Apibal S, 2008. Acute monoblastic leukemia in a FeLV-positive cat. J Vet Sci 9:109.
  360. Quackenbush SL, Dean GA, Mullins JI, et al. 1996. Analysis of FeLV-FAIDS provirus burden and productive infection in lymphocyte subsets in vivo. Virology 223:1-9.
  361. Quackenbush SL, Donahue PR, Dean GA, et al. 1990. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol 64:5465-5474.
  362. Quigley JG, Burns CC, Anderson MM, et al. 2000. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 95:1093-1099.
  363. Quimby JM, Elston T, Hawley ,J et al. 2008. Evaluation of the association of Bartonella species, feline herpesvirus 1, feline calicivirus, feline leukemia virus and feline immunodeficiency virus with chronic feline gingivostomatitis. J Feline Med Surg 10:66.
  364. Ramanathan A, Malik PK, Prasad G, 2007. Seroepizootiological survey for selected viral infections in captive Asiatic lions (Panthera leo persica) from western India. J Zoo Wildl Med 38:400.
  365. Ramsauer S, Bay G, Meli M, et al. 2007. Seroprevalence of selected infectious agents in a free-ranging, low-density lion population in the Central Kalahari Game Reserves in Botswana. Clin Vaccine Immunol 14:808.
  366. Reinacher M. 1987. Infektionen mit dem felinen Leukämie-virus (FeLV) bei sezierten Katzen. Kleintierprax 32:65-72.
  367. Reinacher M. 1989. Disease associated with spontaneous feline leukemia virus (FeLV) infection in cats. Vet Immunol Immunopathol 21:85-95.
  368. Reinacher M, Wittmer G, Koberstein H, et al. 1995. The significance of FeLV infection for diseases in necropsied cats. Berl Munch Tierarztl Wochenschr 108:58-60.
  369. Reinemeyer CR, Faulkner CT, Assadi-Rad AM, et al. 1995. Comparison of the efficacies of three heartworm preventives against experimentally induced infections with Ancylostoma caninum and Toxocara canis in pups. J Am Vet Med Assoc 206:1710-1715.
  370. Rey MA, Prasad R, Tailor CS. 2008. The C domain in the surface envelope glycoprotein of subgroup C feline leukemia virus is a second receptor-binding domain. Virology 370:273.
  371. Rezanka LJ, Rojko JL, Neil JC. 1992. Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest 10:371-389.
  372. Richards JR, Elston TH, Ford RB, et al. 2006. The 2006 American Association of Feline Practitioners feline vaccine advisory panel report. J Am Vet Med Assoc 229:1405.
  373. Rickard CG, Post JE, DeNoronha F, et al. 1973. Interspecies infection by feline leukemia virus: serial cell-free transmission in dogs of malignant lymphoma induced by feline leukemia virus, pp. In Dutcher RM, Chieco-Bianchi L (eds): Unifying concepts of leukemia. Karger, Basel, Switzerland.
  374. Rickard CG, Post JE, Noronha F, et al. 1969. A transmissible virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst 42:987-1014.
  375. Riedel N, Hoover EA, Gasper PW, et al. 1986. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol 60:242-250.
  376. Robertson SJ, Hasenkrug KJ, Chesebro B, et al. 1997. Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells. J Virol 71:5287-5294.
  377. Robinson A, DeCann K, Aitken E, et al. 1998. Comparison of a rapid immunomigration test and ELISA for FIV antibody and FeLV antigen testing in cats. Vet Rec 142:291-292.
  378. Rogers R, Merigan TC, Hardy WD Jr, et al. 1972. Cat interferon inhibits feline leukaemia virus infection in cell culture. Nat New Biol 237:270-271.
  379. Rohn JL, Linenberger ML, Hoover EA. 1994. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J Virol 68:2458-2467.
  380. Rojko JL, Essex M, Trainin Z. 1988. Feline leukemia/sarcoma viruses and immunodeficiency. Adv Vet Sci Comp Med 32:57-96.
  381. Rojko JL, Hardy WD. 1994. Feline leukemia virus and other retroviruses, pp 263-432. In Sherding RG (ed): The cat diseases and clinical management, ed 2. Churchill Livingstone, New York.
  382. Rojko JL, Hoover EA, Mathes LE, et al. 1979. Pathogenesis of experimental feline leukemia virus infection. J Natl Cancer Inst 63:759.
  383. Rojko JL, Hoover EA, Quackenbush SL, et al. 1982. Reactivation of latent feline leukaemia virus infection. Nature 298:385-388.
  384. Rojko JL, Kociba GJ. 1991. Pathogenesis of infection by the feline leukemia virus. J Am Vet Med Assoc 199:1305-1310.
  385. Rojko JL, Kociba GJ, Abkowitz JL, et al. 1989. Feline lymphomas: immunological and cytochemical characterization. Cancer Res 49:345-351.
  386. Romatowski J, Lubkin SR. 1997. Use of an epidemiologic model to evaluate feline leukemia virus control measures. Feline Pract 25:6-11.
  387. Russell PH, Jarrett O. 1978. The specificity of neutralizing antibodies to feline leukaemia viruses. Int J Cancer 21:768.
  388. Ryrfeldt A, Nordgren T, Lundstrom J. 1992. Hypocalcemia induced by foscarnet (Foscavir) infusion in dogs. Fundam Appl Toxicol 18:126-130.
  389. Sakaguchi S, Baba K, Ishikawa M, et al. 2008. Focus assay on RD114 virus in QN10S cells. J Vet Med Sci 70:1383.
  390. Sand C, Englert T, Egberink H, et al. 2009. Evaluation of a new in-clinic test system to detect feline immunodeficiency virus and feline leukemia virus infection. Vet Clin Pathol 39:210-214.
  391. Sanders VJ, Wiley CA, Hamilton RL. 2001. The mechanisms of neuronal damage in retroviral infections of the nervous system. Curr Top Microbiol Immunol 253:179-201.
  392. Sarma PS, Log T, Jain D, et al. 1975. Differential host range of viruses of feline leukemia-sarcoma complex. Virology 2:438-446.
  393. Sarma PS, Log T, Skuntz S, et al. 1978. Experimental horizontal transmission of feline leukemia viruses of subgroups A, B and C. J Natl Cancer Inst 60:871-874.
  394. Scarlett JM, Pollock R. 1991. Year two of follow-up evaluation of a randomized, blind field trial of a commercial feline leukemia virus vaccine. J Am Vet Med Assoc 199:1431-1432.
  395. Schrenzel MD, Higgins RJ, Hinrichs SH, et al. 1990. Type C retroviral expression in spontaneous feline olfactory neuroblastomas. Acta Neuropathol 80:547-553.
  396. Seo KW, Choi US, Bae BK, et al. 2006. Mediastinal lymphoma in a young Turkish Angora cat. J Vet Sci 7:199.
  397. Seguin B. 2002. Injection site sarcomas in cats. Clin Tech Small Anim Pract 17:168-173.
  398. Shalev Z, Duffy SP, Adema KW, et al. 2009. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection. J Virol 83:6706.
  399. Shaw SC, Kent MS, Gordon IK, et al. 2009. Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). J Am Vet Med Assoc 234:376.
  400. Sheets MA, Unger BA, Giggleman GF Jr, et al. 1991. Studies of the effect of acemannan on retrovirus infections: clinical stabilization of feline leukemia virus-infected cats. Mol Biother 3:41-45.
  401. Sheets RL, Pandey R, Jen WC, et al. 1993. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas. J Virol 67:3118-3125.
  402. Shelton GH, Grant CK, Cotter SM, et al. 1990. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acquir Immune Defic Syndr 3:623-630.
  403. Shelton GH, Linenberger ML. 1995. Hematologic abnormalities associated with retrovirus abnormalities in the cat. Semin Vet Med Surg 10:220-233.
  404. Shi Y, Roy-Burman P. 2000. A novel truncated env gene isolated from a feline leukemia virus-induced thymic lymphosarcoma. J Virol 74:1451-1456.
  405. Shimoda T, Shiranaga N, Mashita T, et al. 2000. Bone marrow necrosis in a cat infected with feline leukemia virus. J Vet Med Sci 62:113-115.
  406. Shimoda T, Shiranaga N, Mashita T, et al. 2000. Chronic myelomonocytic leukemia in a cat. J Vet Med Sci 62:195-197.
  407. Shimoda T, Shiranaga N, Mashita T, et al. 2000. A hematological study on thirteen cats with myelodysplastic syndrome. J Vet Med Sci 62:59-64.
  408. Shojima T, Nakata R, Miyazawa T. 2006. Host cell range of T-lymphotropic feline leukemia virus in vitro. Biochem Biophys Res Commun 345:1466.
  409. Sierra P, Guillot J, Jacob H, et al. 2000. Fungal flora on cutaneous and mucosal surfaces of cats infected with feline immunodeficiency virus or feline leukemia virus. Am J Vet Res 61:158-161.
  410. Simon D, Eberle N, Laacke-Singer L, et al. 2008. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats. J Vet Intern Med 22:394.
  411. Sleeman JM, Keane JM, Johnson JS, et al. 2001. Feline leukemia virus in a captive bobcat. J Wildl Dis 37:194-200.
  412. Snyder HW Jr, Ernst NR, Grosmaire LS, et al. 1987. Selective removal of antigen-complexed IgG from cat plasma by adsorption onto a protein A-silica matrix. J Immunol Methods 101:209-217.
  413. Snyder HW Jr, Hardy WD Jr, Zuckermann EE, et al. 1978. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells. Nature 275:656-658.
  414. Snyder SP, Singhal MC, Zuckermann EE, et al. 1983. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70. Virology 131:315-327.
  415. Soe LH, Devi BG, Mullins JI, et al. 1983. Molecular cloning and characterization of endogenous feline leukemia virus sequences from a cat genomic library. J Virol 46:829.
  416. Solano-Gallego L, Hegarty B, Espada Y, et al. 2006. Serological and molecular evidence of exposure to arthropod-borne organisms in cats from northeastern Spain. Vet Microbiol 118:274.
  417. Sourvinos G, Tsatsanis C, Spandidos DA. 2000. Mechanisms of retrovirus-induced oncogenesis. Folia Biol 46:226-232.
  418. Sparkes AH. 2003. Feline leukaemia virus and vaccination. J Feline Med Surg 5:97.
  419. Spodnick GJ, Berg J, Moore FM, et al. 1992. Spinal lymphoma in cats: 21 cases (1976-1989). J Am Vet Med Assoc 200:373-376.
  420. Steed VP. 1987. Improved survival of four cats infected with feline leukemia virus after oral administration of interferon. Feline Pract 17:24-30.
  421. Steele KE, Saunders GK, Coleman GD. 1997. T-cell-rich B-cell lymphoma in a cat. Vet Pathol 34:47-49.
  422. Stiles J, Bienzle D, Render JA, et al. 1999. Use of nested polymerase chain reaction (PCR) for detection of retroviruses from formalin-fixed, paraffin-embedded uveal melanomas in cats. Vet Ophthalmol 2:113-116.
  423. Stokes CR, Finerty S, Gruffydd-Jones TJ, et al. 1999. Mucosal infection and vaccination against feline immunodeficiency virus. J Biotechnol 73:213-221.
  424. Stokol T, Blue JT. 1999. Pure red cell aplasia in cats: 9 cases (1989–1997). J Am Vet Med Assoc 214:75-79
  425. Stützer B, Müller F, Majzoub M, et al. 2010. Role of latent feline leukemia virus infection in nonregenerative cytopenias of cats. J Vet Intern Med 24:192-197.
  426. 419a. Suntz M, Failing K, m Hecht W, et al. 2010. High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings. Vet Immunol Immunopathol 136:71-80.
  427. Swango LJ. 1991. Evaluation of feline leukemia virus diagnostic tests available for in-office use by veterinarians. J Am Vet Med Assoc 199:1386-1388.
  428. Swenson CL, Polas PJ, Cheney CM, et al. 1991. Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro. Am J Vet Res 52:2010-2015.
  429. Sykes JE, Terry JC, Lindsay LL, et al. 2008. Prevalences of various hemoplasma species among cats in the United States with possible hemoplasmosis. J Am Vet Med Assoc 232:372.
  430. Tailor CS, Willett BJ, Kabat D. 1999. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol 73:6500-6505.
  431. Takase-Yoden S, Watanabe R. 1997. Unique sequence and lesional tropism of a new variant of neuropathogenic friend murine leukemia virus. Virology 233:411-422.
  432. Tandon R, Cattori V, Pepin AC, et al. 2008. Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats. Virus Res 135:136.
  433. Tandon R, Cattori V, Willi B, et al. 2007. Copy number polymorphism of endogenous feline leukemia virus-like sequences. Mol Cell Probes 21:257.
  434. Tartaglia J, Jarrett O, Neil JC, et al. 1993. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. J Virol 67:2370-2375.
  435. 427a. Tasker S, Murray JK, Knowles TG, et al. 2010. Coombs’ haemoplasma and retrovirus testing in feline anemia. J Small Anim Pract 51:192-199.
  436. Tavares L, Roneker C, Postie L, et al. 1989. Testing of nucleoside analogues in cats infected with feline leukemia virus: a model. Intervirology 30:26-35.
  437. Taylor SS, Goodfellow MR, Browne WJ, et al. 2009. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats. J Small Anim Pract 50:584.
  438. Teske E, van Straten G, van Noort R, et al. 2002. Chemotherapy with cyclophosphamide, vincristine, and prednisolone (COP) in cats with malignant lymphoma: new results with an old protocol. J Vet Intern Med 16:179-186.
  439. Theilen GH, Snyder SN, Wolfe LG, et al. 1970. Biological studies with viral-induced fibrosarcoma in cats, dogs, rabbits and non-human primates. In Dutcher RM (ed): Comparative leukemia research 1969. Proceedings of the 4th International Symposium on Comparative Leukemia Research, Cherry Hill, NJ, Karger, Basel, Switzerland.
  440. Tizard I. 1991. Use of immunomodulators as an aid to clinical management of feline leukemia virus–infected cats. J Am Vet Med Assoc 199:1482-1484.
  441. Tobey JC, Houston DM, Breuer GJ, et al. 1994. Cutaneous T-cell lymphoma in a cat. J Am Vet Med Assoc 204:606-609.
  442. Todaro GJ, Tevethia S, Meinick J. 1974. Isolation of an RD 114-related Type C virus from feline sarcoma virus transformed baboon cells. Intervirology 1:399-404.
  443. Tomkins MB, Cummins JM. 1982. Response of FeLV-induced nonregenerative anemia to oral administration of a bovine interferon-containing preparation. Feline Pract 12:6-15.
  444. Torres AN, Mathiason CK, Hoover EA. 2005. Re-examination of feline leukemia virus: host relationships using real-time PCR. Virology 332:272.
  445. Torres AN, O’Halloran KP, Larson LJ, et al. 2008. Development and application of a quantitative real-time PCR assay to detect feline leukemia virus RNA. Vet Immunol Immunopathol 123:81.
  446. Torres AN, O’Halloran KP, Larson LJ, et al. 2010. Feline leukemia virus immunity induced by whole inactivated virus vaccination. Vet Immunol Immunopathol 134:122-131.
  447. Tsatsanis C, Fulton R, Nishigaki K. 1994. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J Virol 68:8296-8303.
  448. Tuomari DL, Olsen RG, Singh VK, et al. 1984. Detection of circulating immune complexes by a Clq/protein A-ELISA during the preneoplastic stages of feline leukemia virus infection. Vet Immunol Immunopathol 7:227-238.
  449. Ueland K, Lutz H. 1992. Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway. Zentralbl Veterinarmed B 39:53.
  450. Uthman A, Moestl K, Zetner K, et al. 1996. Detection of sequences of feline leukemia virus in chronically inflamed oral tissue of FeLV-non-viremic cats by using polymerase chain reaction. Wien Tierarztl Monatsschr 83:195-198.
  451. Vail DM, Moore AS, Ogilvie GK, et al. 1998. Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats. J Vet Intern Med 12:349-354.
  452. Valli VE, Jacobs RM, Norris A. 1995. Pathology of feline lymphoma, Proceedings of the Veterinary Cancer Society 15:57.
  453. Valli VE, Jacobs RM, Norris A, et al. 2000. The histologic classification of 602 cases of feline lymphoproliferative disease using the National Cancer Institute working formulation. J Vet Diagn Invest 12:295-306.
  454. Vascellari M, Melchiotti E, Bozza MA, et al. 2003. Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. J Vet Med A Physiol Pathol Clin Med 50:286.
  455. Vedbrat SS, Rasheed S, Lutz H, et al. 1983. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas. Virology 124:445-461.
  456. Vobis M, D’Haese J, Mehlhorn H, et al. 2003. Evidence of horizontal transmission of feline leukemia virus by the cat flea (Ctenocephalides felis). Parasitol Res 91:467-470.
  457. Vobis M, D’Haese J, Mehlhorn H, et al. 2003. The feline leukemia virus (FeLV) and the cat flea (Ctenocephalides felis). Parasitol Res 90:132-134.
  458. Vobis M, D’Haese J, Mehlhorn H, et al. 2003. The feline leukemia virus (FeLV) and the cat flea (Ctenocephalides felis). Parasitol Res 90(Suppl 3):S132-S134.
  459. Wang J, Kyaw-Tanner M, Lee C, et al. 2001. Characterisation of lymphosarcomas in Australian cats using polymerase chain reaction and immunohistochemical examination. Aust Vet J 79:41-46.
  460. Weijer K, Uyt de Haag FG, Jarrett O, et al. 1986. Post-exposure treatment with monoclonal antibodies in a retrovirus system: failure to protect cats against feline leukemia virus infection with virus neutralizing monoclonal antibodies. Int J Cancer 38:81.
  461. Weijer K, Uijt de Haag F, Osterhaus A. 1986. Control of feline leukaemia virus infection by a removal programme. Vet Rec 119:555-556.
  462. Weijer K, van Herwijnen R. 1995. Detection of FeLV antigen. Vet Rec 137:127.
  463. Weiss RC. 1988. Immunotherapy for feline leukemia, using staphylococcal protein A or heterologous interferons: immunopharmacologic actions and potential use. J Am Vet Med Assoc 192:681-684.
  464. Weiss DJ. 2006. Aplastic anemia in cats—clinicopathological features and associated disease conditions 1996-2004. J Feline Med Surg 8:203.
  465. Weiss RC, Cummins JM, Richards AB. 1991. Low-dose orally administered alpha interferon treatment for feline leukemia virus infection. J Am Vet Med Assoc 199:1477-1481.
  466. Willemse MJ, Schooneveld SH, Chalmers WS, et al. 1996. Vaccination against feline leukemia using a new feline herpesvirus type-1 vector. Vaccine 14:1511-1516.
  467. Willi B, Boretti FS, Baumgartner C, et al. 2006. Prevalence, risk factor analysis, and follow-up of infections caused by three feline hemoplasma species in cats in Switzerland. J Clin Microbiol 44:961.
  468. Willi B, Filoni C, Catão-Dias JL, et al. 2007. Worldwide occurrence of feline hemoplasma infections in wild felid species. J Clin Microbiol 45:1159.
  469. Willis AM. 2000. Feline leukemia virus and feline immunodeficiency virus. Vet Clin North Am Small Anim Pract 30:971-986
  470. Yilmaz H, Ilgaz A, Harbour DA. 2000. Prevalence of FIV and FeLV infections in cats in Istanbul. J Feline Med Surg 2:69.
  471. Young NS, Abkowitz JL, Luzzatto L. 2000. New insights into the pathophysiology of acquired cytopenias. Hematology (Am Soc Hematol Educ Prog) 2000:18-38.
  472. Yu YE, Choe W, Zhang W, et al. 1997. Development of pathological lesions in the central nervous system of transgenic mice expressing the env gene of ts1 Moloney murine leukemia virus in the absence of the viral gag and pol genes and viral replication. J Neurovirol 3:274-282.
  473. Zeidner NS, Mathiason-DuBard CK, Hoover EA. 1995. Reversal of feline leukemia virus infection by adoptive transfer of activated T lymphocytes, interferon alpha and zidovudine, Semin Vet Med Surg 10:256-266.
  474. Zeidner NS, Myles MH, Mathiason-DuBard CK, et al. 1990. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Antimicrob Agents Chemother 34:1749-1756.
  475. Zeidner NS, Rose LM, Mathiason-Dubard CK, et al. 1990. Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS). J Acquir Immune Defic Syndr 3:787-796.
  476. Zenger E. 2000. FIP, FeLV, FIV: making a diagnosis. Feline Pract 28:16-18.